- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular imaging using PET for breast cancer
Authors
Keywords
Breast cancer, PET, Molecular imaging, Molecular target therapy, HER2
Journal
Breast Cancer
Volume 23, Issue 1, Pages 24-32
Publisher
Springer Nature
Online
2015-04-27
DOI
10.1007/s12282-015-0613-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of MRI in Breast Cancer Screening
- (2017) Constance D. Lehman et al. Journal of the National Comprehensive Cancer Network
- Molecular Ultrasound Imaging Using a Targeted Contrast Agent for Assessing Early Tumor Response to Antiangiogenic Therapy
- (2017) Anna G. Sorace et al. JOURNAL OF ULTRASOUND IN MEDICINE
- PET/CT-Derived Whole-Body and Bone Marrow Dosimetry of 89Zr-Cetuximab
- (2015) N. E. Makris et al. JOURNAL OF NUCLEAR MEDICINE
- Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT
- (2013) Judith E. Kalinyak et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: Lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues
- (2013) Leonardo Pace et al. EUROPEAN JOURNAL OF RADIOLOGY
- 89Zr-Bevacizumab PET Imaging in Primary Breast Cancer
- (2013) S. B. M. Gaykema et al. JOURNAL OF NUCLEAR MEDICINE
- Feasibility and Predictability of Perioperative PET and Estrogen Receptor Ligand in Patients with Invasive Breast Cancer
- (2013) M. L. Gemignani et al. JOURNAL OF NUCLEAR MEDICINE
- 64Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer
- (2013) K. Tamura et al. JOURNAL OF NUCLEAR MEDICINE
- Functional Imaging of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Using 64Cu-DOTA-Trastuzumab PET
- (2013) J. E. Mortimer et al. JOURNAL OF NUCLEAR MEDICINE
- Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas
- (2013) Sibaprasad Bhattacharyya et al. NUCLEAR MEDICINE AND BIOLOGY
- Performance of FDG PET/CT in the Clinical Management of Breast Cancer
- (2012) David Groheux et al. RADIOLOGY
- Stability of HER2-positive status in breast carcinoma: a comparison between primary and paired metastatic tumors with regard to the possible impact of intervening trastuzumab treatment
- (2011) C. Xiao et al. ANNALS OF ONCOLOGY
- HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis
- (2011) Nehmat Houssami et al. BREAST CANCER RESEARCH AND TREATMENT
- Development of [F-18]Fluorine-Substituted Tanaproget as a Progesterone Receptor Imaging Agent for Positron Emission Tomography
- (2010) Jae Hak Lee et al. BIOCONJUGATE CHEMISTRY
- Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
- (2010) E C Dijkers et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Contrast-enhanced ultrasound for molecular imaging of angiogenesis
- (2010) J. R. Eisenbrey et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Reliability of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry in Breast Core Needle Biopsies
- (2010) Annette Lebeau et al. JOURNAL OF CLINICAL ONCOLOGY
- Association between serial dynamic contrast-enhanced MRI and dynamic 18F-FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer
- (2010) Savannah C. Partridge et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- ImmunoSPECT and ImmunoPET of IGF-1R Expression with the Radiolabeled Antibody R1507 in a Triple-Negative Breast Cancer Model
- (2010) S. Heskamp et al. JOURNAL OF NUCLEAR MEDICINE
- Altered Tissue 3'-Deoxy-3'-[18F]Fluorothymidine Pharmacokinetics in Human Breast Cancer following Capecitabine Treatment Detected by Positron Emission Tomography
- (2009) L. M. Kenny et al. CLINICAL CANCER RESEARCH
- Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations
- (2009) Guido Sauter et al. JOURNAL OF CLINICAL ONCOLOGY
- The prognostic importance of triple negative breast carcinoma
- (2008) Hakan Mersin et al. BREAST
- Triple-Negative Breast Cancer: Risk Factors to Potential Targets
- (2008) B. P. Schneider et al. CLINICAL CANCER RESEARCH
- Immunoscintigraphy as Potential Tool in the Clinical Evaluation of HER2/neu Targeted Therapy
- (2008) Eli Dijkers et al. CURRENT PHARMACEUTICAL DESIGN
- Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and 18F-Fluoroestradiol
- (2008) L. M. Peterson et al. JOURNAL OF NUCLEAR MEDICINE
- Patterns of v 3 Expression in Primary and Metastatic Human Breast Cancer as Shown by 18F-Galacto-RGD PET
- (2008) A. J. Beer et al. JOURNAL OF NUCLEAR MEDICINE
- Recommendations on the Use of 18F-FDG PET in Oncology
- (2008) J. W. Fletcher et al. JOURNAL OF NUCLEAR MEDICINE
- Assessing the future of diffuse optical imaging technologies for breast cancer management
- (2008) Bruce J. Tromberg et al. MEDICAL PHYSICS
- Breast-specific Gamma Imaging as an Adjunct Imaging Modality for the Diagnosis of Breast Cancer
- (2008) Rachel F. Brem et al. RADIOLOGY
- PET/CT supports breast cancer diagnosis and treatment
- (2008) Mitsuhiro Hayashi et al. Breast Cancer
- Metabolite quantification and high-field MRS in breast cancer
- (2007) Ihab S. Haddadin et al. NMR IN BIOMEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started